# Docetaxel - Carboplatin As Second Line Treatment in Patients with Small Cell Lung Cancer

> **NCT00686985** · PHASE2 · COMPLETED · sponsor: **Dr. B. Biesma** · enrollment: 50 (actual)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **DRUG:** Carboplatin, docetaxel

## Key facts

- **NCT ID:** NCT00686985
- **Lead sponsor:** Dr. B. Biesma
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00686985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00686985, "Docetaxel - Carboplatin As Second Line Treatment in Patients with Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00686985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*